A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models
Epizyme (United States) · Agile Therapeutics (United States) · +1 more institution
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
544
total citations
- FWCI
- 22.44
- Percentile
- 100%
- References
- 56
Citations per year
Authors
30Topics & keywords
Keywords
- Protein arginine methyltransferase 5
- In vivo
- Methyltransferase
- Carcinogenesis
- Methylation
- Chemistry
- Arginine
- Arginine deiminase
UN Sustainable Development Goals
- Zero hunger
No related works found for this paper.